129 related articles for article (PubMed ID: 8182006)
1. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
[TBL] [Abstract][Full Text] [Related]
2. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
[TBL] [Abstract][Full Text] [Related]
3. Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.
Kluge RM; Spaulding DM; Spain AJ
Antimicrob Agents Chemother; 1978 Jun; 13(6):975-8. PubMed ID: 307941
[TBL] [Abstract][Full Text] [Related]
4. The scid mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy.
Kunz S; Junker U; Blaser J; Joos B; Meyer B; Zak O; O'Reilly T
J Antimicrob Chemother; 1995 Jul; 36(1):137-55. PubMed ID: 8537261
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole.
Price DA; Hollings NP; Janes SM; Main J; Coker RJ
J Antimicrob Chemother; 1994 Aug; 34(2):303. PubMed ID: 7814298
[No Abstract] [Full Text] [Related]
6. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
[TBL] [Abstract][Full Text] [Related]
7. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH
Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Hughes WT; Killmar JT; Oz HS
J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
[TBL] [Abstract][Full Text] [Related]
10. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
11. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
[TBL] [Abstract][Full Text] [Related]
12. Tracheal aspirate examination for Pneumocystis carinii cysts as a guide to therapy in pneumocystis pneumonia.
Trigg ME; Kohn DB; Sondel PM; Chesney PJ
J Pediatr; 1983 Jun; 102(6):881-3. PubMed ID: 6602215
[No Abstract] [Full Text] [Related]
13. Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
Hughes WT; Smith BL; Jacobus DP
Antimicrob Agents Chemother; 1986 Mar; 29(3):509-10. PubMed ID: 3487287
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Williams DE; Rosenberg C
Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
[TBL] [Abstract][Full Text] [Related]
15. Employment of terbinafine against Pneumocystis carinii infection in rat models.
Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R
Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.
Smith D; Davies S; Nelson M; Youle M; Gleeson J; Gazzard B
AIDS; 1990 Oct; 4(10):1019-21. PubMed ID: 2261116
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii pneumonitis successfully treated with trimethoprim-sulphamethoxazole.
McLennan G; Antic R; Seymour AE; Frith PA; Clarkson AR
Aust N Z J Med; 1977 Jun; 7(3):299-301. PubMed ID: 303097
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.
Hughes WT; McNabb PC; Makres TD; Feldman S
Antimicrob Agents Chemother; 1974 Mar; 5(3):289-93. PubMed ID: 4365115
[TBL] [Abstract][Full Text] [Related]
19. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
Sheehan PM; Stokes DC; Yeh YY; Hughes WT
Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
[TBL] [Abstract][Full Text] [Related]
20. Chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
JAMA; 1988 Aug; 260(7):921-2. PubMed ID: 3260965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
